Sure Med Compliance Appoints Dr. Steven Passik to Enhance Pain Management and Addiction Services

On September 18, 2025, Sure Med Compliance made a significant announcement by appointing Dr. Steven D. Passik, PhD, as the new Chief Clinical Officer. Known for its leadership in compliance and risk mitigation services for pain management providers, Sure Med is looking to bolster its initiatives in both pain treatment and Substance Use Disorder (SUD). This strategic appointment aims to widen the company’s footprint in these crucial areas, addressing the urgent need for comprehensive treatment options across the nation.

Dr. Passik brings over 25 years of invaluable experience in clinical psychology, addiction research, and pain management. His most recent position was as Vice President of Scientific Affairs at Millennium Health, where he played a pivotal role in clinical data programs and advancing scientific affairs. His extensive background includes notable tenures at respected institutions such as Memorial Sloan Kettering Cancer Center, Vanderbilt University, and the University of Kentucky. Here, he engaged in research and clinical work that intersects cancer pain and psychological comorbidities, significantly enhancing protocols in pain and addiction management.

In his new role, Dr. Passik is expected to lead Sure Med’s expansion into SUD services while also enhancing its current offerings in pain management. His expertise has been instrumental in shaping policies surrounding medication monitoring and opioid risk management. His contributions have positioned Sure Med as a thought leader in the industry, focusing on improving patient outcomes through innovative methodologies.

Moreover, Dr. Passik’s active involvement with the International Health Facility Diversion Association (IHFDA) demonstrates his commitment to reducing drug diversion risks in healthcare. His board membership with Drug Free Clubs of America, which emphasizes substance use prevention among high school students, showcases his dedication to addressing addiction from various societal perspectives.

With the launch of the Perspectives in Care platform, a technology designed to enhance SUD management, Dr. Passik's arrival is timely. This tool aims to empower clinicians by improving their ability to assess and treat patients in a compliant and effective manner, thus fostering better patient access to necessary care. Dr. Passik expressed excitement about joining Sure Med, stating, "I am honored and excited to be joining Sure Med Compliance as Chief Clinical Officer, particularly as the timing corresponds to the release of the Perspectives in Care platform for the management of SUD."

CEO John Bowman affirmed the significance of Dr. Passik's appointment, highlighting that his extensive research and application in improving patient outcomes will catalyze a pivotal shift in Sure Med’s mission. He emphasized that this alignment could lead to new products and services that potentially redefine industry standards and significantly enhance patients' lives.

Sure Med Compliance specializes in helping providers navigate the often complicated landscape of pain management and substance use disorder. Through a combination of compliance consulting, monitoring technologies, and educational support, the organization is dedicated to delivering safe and effective patient care. This latest appointment marks an exciting chapter for Sure Med, as it endeavors to not only expand its clinical leadership but also its holistic approach to managing pain and addiction effectively, providing vital support to clinicians and patients alike.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.